e-learning
resources
Virtual 2020
Pre-Congress Content
Personalised treatment of obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Regulatory T cells and L-selectin in severe asthmatic patients treated with mepolizumab.
l. bergantini (siena, Italy), M. D'Alessandro (siena, Italy), P. Cameli (siena, Italy), A. Carleo (hannover , Germany), P. Sestini (siena, Italy), E. Bargagli (siena, Italy)
Source:
Virtual Congress 2020 – Personalised treatment of obstructive diseases
Session:
Personalised treatment of obstructive diseases
Session type:
E-poster session
Number:
2667
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
l. bergantini (siena, Italy), M. D'Alessandro (siena, Italy), P. Cameli (siena, Italy), A. Carleo (hannover , Germany), P. Sestini (siena, Italy), E. Bargagli (siena, Italy). Regulatory T cells and L-selectin in severe asthmatic patients treated with mepolizumab.. 2667
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Inflammatory process of CD8
+
CD28
-
T cells in induced sputum from asthmatic patients
Source: Eur Respir J 2005; 26: Suppl. 49, 25s
Year: 2005
Reduced numbers of circulating CD4
+
CD25
high
FOXP3
+
regulatory T cells in patients with allergic asthma
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
Expression of surface markers on peripheral CD4
+
CD25
high
T cells in patients with atopic asthma: role of inhaled corticosteroid
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
CD4+CD25+ T lymphocytes in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 319s
Year: 2004
Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
The declined CD4+ CD25+Treg cells in patients with moderate to severe asthma associated with over-expressed Th2 response
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
Diminished levels of IL-7 receptor-positive CD4+ T cells in asthmatic patients are up-regulated by glucocorticoid therapy. No effects on IL-7R-negative regulatory CD4+ T cells
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010
Study of the effect of IL-4 and IFN-γ on Th1/Th2 cells and mast cells in allergic asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001
Enhanced expression of IL-18 and increased CD8+ T cells and eosinophils in the airways of asthma death
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010
Increased levels of CD4+CD25high and CD4+FoxP3+ T-regulatory cells (Tregs) in patients with different severity of bronchial asthma (BA)
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011
Steroid insensitivity of airway T lymphocytes in COPD patients
Source: Annual Congress 2009 - Pathology and immunology of COPD
Year: 2009
Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Theophylline and budesonide downregulate production of cytokines by blood T lymphocytes of patients with COPD
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Effects of depletion of CD4+CD25+ T cells with anti-CD25McAb on airway inflammation of asthmatic mice
Source: Eur Respir J 2005; 26: Suppl. 49, 24s
Year: 2005
Different profiles of lung and systemic regulatory T cells in mild asthmatics
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
Characteristics of fatal asthma: CD8 positive T cells producing IFN-γ and IL-18 were recruited into small airways in fatal asthma
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Regulatory T cells in human asthma
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010
Upregulation of CD4+ and CD8+ cells expressing CX3CR1 in asthmatics
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept